Skip to content
PubMed This is a summary of 59 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 59 referenced papers

Top Authors

Luigi Daniele Notarangelo
National Institutes of Health
Christopher C. Dvorak
University of California, San Francisco
David I. Yule
University of Rochester Medicine
Jordan Scott Orange
Children's Hospital of Philadelphia
Austen J. J. Worth
Great Ormond Street Hospital
Holm Schneider
Friedrich-Alexander-Universität Erlangen-Nürnberg
Adrian Liston
Babraham Institute
Julika Neumann
VIB-KU Leuven Center for Brain & Disease Research

Top Institutions

Ranked by publications Top 10 institutions

References

References (59)
  1. 1

    Dental Implant Therapy for a Child with X-linked Hypohidrotic Ectodermal Dysplasia--Three Decades of Managed Care.

    Bergendal B, Bjerklin K, Bergendal T, Koch G

    The International journal of prosthodontics 2015; (28(4)):348-56 doi:10.11607/ijp.4242.

    PMID: 26218015
  2. 2

    Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations.

    Lee PP

    Annals of the Academy of Medicine, Singapore 2015; (44(8)):297-301.

    PMID: 26477962
  3. 3

    [HOW TO APPROACH A PATIENT WITH SUSPECTED IMMUNODEFICIENCY].

    Toker O, Aggmon-Levin N, Somech R

    Harefuah 2016; (155(3)):170-6, 195.

    PMID: 27305752
  4. 4

    Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.

    Ogonek J, Kralj Juric M, Ghimire S, et al.

    Frontiers in immunology 2016; (7()):507 doi:10.3389/fimmu.2016.00507.

    PMID: 27909435
  5. 5

    Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase δ syndrome type 1.

    Okano T, Imai K, Tsujita Y, et al.

    The Journal of allergy and clinical immunology 2019; (143(1)):266-275 doi:10.1016/j.jaci.2018.04.032.

    PMID: 29778502
  6. 6

    Phenotypic Features and Salivary Parameters in Patients with Ectodermal Dysplasia: Report of Three Cases.

    Gomes MF, Sichi LGB, Giannasi LC, et al.

    Case reports in dentistry 2018; (2018()):2409212 doi:10.1155/2018/2409212.

    PMID: 29854479
  7. 7

    A case report of hypohidrotic ectodermal dysplasia: A mini-review with latest updates.

    Meshram GG, Kaur N, Hura KS

    Journal of family medicine and primary care 2018; (7(1)):264-266 doi:10.4103/jfmpc.jfmpc_20_17.

    PMID: 29915774
  8. 8

    SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.

    Haddad E, Logan BR, Griffith LM, et al.

    Blood 2018; (132(17)):1737-1749 doi:10.1182/blood-2018-03-840702.

    PMID: 30154114
  9. 9

    Primary immunodeficiency.

    McCusker C, Upton J, Warrington R

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2018; (14(Suppl 2)):61 doi:10.1186/s13223-018-0290-5.

    PMID: 30275850
  10. 10

    Oral Care Program for Successful Long-Term Full Mouth Habilitation of Patients with Hypohidrotic Ectodermal Dysplasia.

    Hsieh YL, Razzoog M, Garcia Hammaker S

    Case reports in dentistry 2018; (2018()):4736495 doi:10.1155/2018/4736495.

    PMID: 30627453
  11. 11

    Balance impairment in pediatric charcot-marie-tooth disease.

    Estilow T, Glanzman AM, Burns J, et al.

    Muscle & nerve 2019; (60(3)):242-249 doi:10.1002/mus.26500.

    PMID: 31026080
  12. 12

    Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives.

    Castagnoli R, Delmonte OM, Calzoni E, Notarangelo LD

    Frontiers in pediatrics 2019; (7()):295 doi:10.3389/fped.2019.00295.

    PMID: 31440487
  13. 13

    Dental Rehabilitation of a Child with Ectodermal Dysplasia: A Case Report.

    Gholman RR, Kassar WM, El Meligy OA

    International journal of clinical pediatric dentistry 2019; (12(4)):362-365 doi:10.5005/jp-journals-10005-1651.

    PMID: 31866726
  14. 14

    Systemic BK Virus Infection in a Pediatric Patient With Severe Combined Immunodeficiency.

    Espinosa-González R, E Aguilar León D, Rodríguez-Jurado R, Uribe-Uribe NO

    Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2020; (23(4)):317-321 doi:10.1177/1093526619892181.

    PMID: 32056495
  15. 15

    Genetics of severe combined immunodeficiency.

    Kumrah R, Vignesh P, Patra P, et al.

    Genes & diseases 2020; (7(1)):52-61 doi:10.1016/j.gendis.2019.07.004.

    PMID: 32181275
  16. 16

    Safety and immunogenicity of Fc-EDA, a recombinant ectodysplasin A1 replacement protein, in human subjects.

    Körber I, Klein OD, Morhart P, et al.

    British journal of clinical pharmacology 2020; (86(10)):2063-2069 doi:10.1111/bcp.14301.

    PMID: 32250462
  17. 17

    Acquired Immunodeficiency from Maternal Chemotherapy and Severe Primary Pneumocystis Infection in an Infant.

    Lim AYL, Mattke AC, Clark JE, et al.

    Case reports in pediatrics 2020; (2020()):5740304 doi:10.1155/2020/5740304.

    PMID: 32257491
  18. 18

    Prosthodontic Management of a Pediatric Patient with Christ-Siemens-Touraine Syndrome: A Case Report.

    Abdulla AM, Almaliki AY, Shakeela NV, et al.

    International journal of clinical pediatric dentistry 2019; (12(6)):569-572 doi:10.5005/jp-journals-10005-1697.

    PMID: 32440077
  19. 19

    Interstitial pneumonia as the initial presentation in an infant with a novel mutation of CD40 ligand-associated X-linked hyper-IgM syndrome: A case report.

    Li J, Miao H, Wu L, Fang Y

    Medicine 2020; (99(24)):e20505 doi:10.1097/MD.0000000000020505.

    PMID: 32541472
  20. 20

    Dominant mutations in ITPR3 cause Charcot-Marie-Tooth disease.

    Rönkkö J, Molchanova S, Revah-Politi A, et al.

    Annals of clinical and translational neurology 2020; (7(10)):1962-1972 doi:10.1002/acn3.51190.

    PMID: 32949214
  21. 21

    Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers.

    Dorsey MJ, Wright NAM, Chaimowitz NS, et al.

    Journal of clinical immunology 2021; (41(1)):38-50 doi:10.1007/s10875-020-00865-9.

    PMID: 33006109
  22. 22

    Clinical warning of hemophagocytic syndrome caused by Epstein-Barr virus.

    Shi J, Chu C, Yu M, et al.

    Italian journal of pediatrics 2021; (47(1)):3 doi:10.1186/s13052-020-00949-7.

    PMID: 33413556
  23. 23

    The impact of orthoses on gait in children with Charcot-Marie-Tooth disease.

    Õunpuu S, Garibay E, Acsadi G, et al.

    Gait & posture 2021; (85()):198-204 doi:10.1016/j.gaitpost.2021.02.005.

    PMID: 33610823
  24. 24

    Ectodermal Dysplasia Presenting as Heat Exhaustion in an Adolescent Boy.

    Guntreddi G, Vasudevan Nair J, Nirujogi SP

    Cureus 2021; (13(2)):e13450 doi:10.7759/cureus.13450.

    PMID: 33767934
  25. 25

    Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia.

    Hennig V, Schuh W, Neubert A, et al.

    Orphanet journal of rare diseases 2021; (16(1)):373 doi:10.1186/s13023-021-02011-z.

    PMID: 34479575
  26. 26

    Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort.

    Lankester AC, Neven B, Mahlaoui N, et al.

    The Journal of allergy and clinical immunology 2022; (149(5)):1744-1754.e8 doi:10.1016/j.jaci.2021.10.017.

    PMID: 34718043
  27. 27

    Growth in diagnosis and treatment of primary immunodeficiency within the global Jeffrey Modell Centers Network.

    Quinn J, Modell V, Orange JS, Modell F

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2022; (18(1)):19 doi:10.1186/s13223-022-00662-6.

    PMID: 35246253
  28. 28

    Activated Phosphoinositide 3-Kinase δ Syndrome: a Large Pediatric Cohort from a Single Center in China.

    Qiu L, Wang Y, Tang W, et al.

    Journal of clinical immunology 2022; (42(4)):837-850 doi:10.1007/s10875-022-01218-4.

    PMID: 35296988
  29. 29

    Disrupted Ca2+ homeostasis and immunodeficiency in patients with functional IP3 receptor subtype 3 defects.

    Neumann J, Van Nieuwenhove E, Terry LE, et al.

    Cellular & molecular immunology 2023; (20(1)):11-25 doi:10.1038/s41423-022-00928-4.

    PMID: 36302985
  30. 30

    Missense mutations in inositol 1,4,5-trisphosphate receptor type 3 result in leaky Ca2+ channels and activation of store-operated Ca2+ entry.

    Terry LE, Arige V, Neumann J, et al.

    iScience 2022; (25(12)):105523 doi:10.1016/j.isci.2022.105523.

    PMID: 36444295
  31. 31

    Infections in Inborn Errors of Immunity with Combined Immune Deficiency: A Review.

    George K, Govindaraj G

    Pathogens (Basel, Switzerland) 2023; (12(2)) doi:10.3390/pathogens12020272.

    PMID: 36839544
  32. 32

    Uncertainties experienced by parents of children diagnosed with severe combined immunodeficiency through newborn screening.

    Raspa M, Kutsa O, Andrews SM, et al.

    European journal of human genetics : EJHG 2024; (32(4)):392-398 doi:10.1038/s41431-023-01345-5.

    PMID: 36973394
  33. 33

    Rare Disease, Advocacy and Justice: Intersecting Disparities in Research and Clinical Care.

    Halley MC, Halverson CME, Tabor HK, Goldenberg AJ

    The American journal of bioethics : AJOB 2023; (23(7)):17-26 doi:10.1080/15265161.2023.2207500.

    PMID: 37204146
  34. 34

    A multiple-oscillator mechanism underlies antigen-induced Ca2+ oscillations in Jurkat T-cells.

    Benson JC, Romito O, Abdelnaby AE, et al.

    The Journal of biological chemistry 2023; (299(11)):105310 doi:10.1016/j.jbc.2023.105310.

    PMID: 37778728
  35. 35

    Comparative study of biomarkers for the early identification of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in infectious mononucleosis.

    Cai L, Xing Y, Xia Y, et al.

    BMC infectious diseases 2023; (23(1)):728 doi:10.1186/s12879-023-08654-6.

    PMID: 37880605
  36. 36

    Use, tolerability, benefits and side effects of orthotic devices in Charcot-Marie-Tooth disease.

    Bertini A, Manganelli F, Fabrizi GM, et al.

    Journal of neurology, neurosurgery, and psychiatry 2024; (95(5)):434-441 doi:10.1136/jnnp-2023-332422.

    PMID: 37918904
  37. 37

    Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.

    Sivera Mascaró R, García Sobrino T, Horga Hernández A, et al.

    Neurologia 2025; (40(3)):290-305 doi:10.1016/j.nrleng.2024.02.008.

    PMID: 38431252
  38. 38

    Parental Engagement in Identifying Information Needs After Newborn Screening for Families of Infants with Suspected Athymia.

    Howley E, Soomann M, Kreins AY

    Journal of clinical immunology 2024; (44(3)):79 doi:10.1007/s10875-024-01678-w.

    PMID: 38457046
  39. 39

    A Clinical Neurological Approach to the Child With Adenosine Deaminase Deficiency.

    Ivarola P, Urdinez L, Oleastro M, et al.

    Pediatric neurology 2024; (158()):49-56 doi:10.1016/j.pediatrneurol.2024.05.022.

    PMID: 38959649
  40. 40

    A pleiotropic recurrent dominant ITPR3 variant causes a complex multisystemic disease.

    Molitor A, Lederle A, Radosavljevic M, et al.

    Science advances 2024; (10(37)):eado5545 doi:10.1126/sciadv.ado5545.

    PMID: 39270020
  41. 41

    ITPR3-associated neuropathy: Report of a further family with adult onset intermediate Charcot-Marie-Tooth disease.

    Cabello-Murgui J, Jiménez-Jiménez J, Vílchez JJ, et al.

    European journal of neurology 2024; (31(12)):e16485 doi:10.1111/ene.16485.

    PMID: 39287469
  42. 42

    Dominant negative variants in ITPR3 impair T cell Ca2+ dynamics causing combined immunodeficiency.

    Blanco E, Camps C, Bahal S, et al.

    The Journal of experimental medicine 2025; (222(1)) doi:10.1084/jem.20220979.

    PMID: 39560673
  43. 43

    IP3 receptor depletion in a spontaneous canine model of Charcot-Marie-Tooth disease 1J with amelogenesis imperfecta.

    Hytönen MK, Rönkkö J, Hundi S, et al.

    PLoS genetics 2025; (21(1)):e1011328 doi:10.1371/journal.pgen.1011328.

    PMID: 39804930
  44. 44

    Expert-Based, Institutional Approaches for Reducing the Diagnostic Odyssey of Patients With Inborn Errors of Immunity.

    Rider NL, Bastarache L, Anderson JT, et al.

    The journal of allergy and clinical immunology. In practice 2025; (13(6)):1317-1324 doi:10.1016/j.jaip.2025.03.040.

    PMID: 40187490
  45. 45

    Inborn errors of immunity: manifestation, treatment, and outcome - an ESID registry 1994-2024 report on 30,628 patients.

    Kindle G, Alligon M, Albert MH, et al.

    medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.02.20.25322586.

    PMID: 40568655
  46. 46

    Physical Therapy Interventions for Gait and Balance in Charcot-Marie-Tooth Disease: A Scoping Review.

    Tedeschi R, Donati D, Giorgi F

    Life (Basel, Switzerland) 2025; (15(7)) doi:10.3390/life15071036.

    PMID: 40724538
  47. 47

    EB virus infection-associated hemophagocytic lymphohistiocytosis complicated with giant axillary lymph nodes: A case report.

    Zhang C, Feng C, Tang W, et al.

    Medicine 2025; (104(32)):e42608 doi:10.1097/MD.0000000000042608.

    PMID: 40797500
  48. 48

    Severe Combined Immunodeficiency in the Newborn Period.

    Salinas Cisneros G, Dvorak CC

    NeoReviews 2025; (26(9)):e600-e614 doi:10.1542/neo.26-9-051.

    PMID: 40887076
  49. 49

    Two cases of combined immunodeficiency with ITPR3 mutations presenting with life-threatening severe EBV-associated hemophagocytic lymphohistiocytosis.

    Yu L, Li Y, Zhang L, et al.

    Frontiers in immunology 2025; (16()):1653662 doi:10.3389/fimmu.2025.1653662.

    PMID: 41019080
  50. 50

    Health-related quality of life of children and adolescents with the most common ectodermal dysplasia: focus group study and item development for a condition-specific patient-reported outcome measure.

    Kügler C, Witt S, Hammersen J, et al.

    Orphanet journal of rare diseases 2026; (21(1)).

    PMID: 41652480
  51. 51

    Axonal-demyelinating differences in functional change in pediatric Charcot-Marie-Tooth and related neuropathies.

    Inmongkol C, Vorasan N, Limpaninlachat S, et al.

    BMC neurology 2026; (26(1)).

    PMID: 42010503
  52. 52

    Unveiling pediatric secondary hemophagocytic lymphohistiocytosis: a comprehensive analysis of etiology, diagnosis, and treatment.

    Liu P, Wang M, Ban C, et al.

    Frontiers in immunology 2026; (17()):1753930 doi:10.3389/fimmu.2026.1753930.

    PMID: 42112374
  53. 53

    Practice parameter for inborn errors of immunity: What is new in the 2025 update.

    Chinen J, Horner CC, Orange JS

    The Journal of allergy and clinical immunology 2026; (158(2)):368-373 doi:10.1016/j.jaci.2026.05.014.

    PMID: 42208906
  54. 54

    Hypohidrotic ectodermal dysplasia syndrome in a Sudanese patient: a case report.

    Mukhtar MA, Amine AAA, Muctar SA, et al.

    The Pan African medical journal 2025; (52()):133 doi:10.11604/pamj.2025.52.133.48575.

    PMID: 42232673
  55. 55

    De novo NFKBIA variants within the N-terminal hotspot: consistent immunophenotype and divergent clinical presentations.

    Gan R, Li G, Zhou L, et al.

    Frontiers in immunology 2026; (17()):1854185 doi:10.3389/fimmu.2026.1854185.

    PMID: 42327742
  56. 56

    Neuromuscular Symptoms of ORAI1-Related Immunodeficiency.

    Jędrzejowska M, Potulska-Chromik A, Czeczko K, et al.

    Journal of child neurology 2026; 8830738261459493 doi:10.1177/08830738261459493.

    PMID: 42390425
  57. 57

    Immune dysregulatory disorders: perspective from solving a diagnostic odyssey.

    Crowther L, Broderick L

    Current opinion in pediatrics 2026; (38(6)):659-665 doi:10.1097/MOP.0000000000001616.

    PMID: 42750655
  58. 58

    [The Great Imposter: Three Cases of Inflammatory Bowel Disease Associated with Innate Immune Defects].

    Hernández DPS, Tamayo SV

    Acta gastroenterologica Latinoamericana 2026; (56(3)):357-364 doi:10.52787/agl.v56i3.597.

    PMID: 42871851
  59. 59

    Jeffrey's Insights: Next-generation sequencing for primary immunodeficiency diagnosis, 2019-2025.

    Quinn J, Fernández-Tabanera E, Perea-Romero I, et al.

    Journal of human immunity 2027; (3(1)) doi:10.70962/jhi.20250192.

    PMID: 42900003